Abstract
The intent of this article is to review recent literature on ribosome inactivating proteins (RIPs) including isolation and characterization of new RIPs, studies on the crystal structures and mechanisms of actions of RIPs, the use of saporin-based neurotoxins to selectively lesion cholinergic neurons in neuroscience research, and the use of RIP-based conjugates and immunotoxins in anticancer therapy.
Current Protein & Peptide Science
Title: Recent Progress in Research on Ribosome Inactivating Proteins
Volume: 11 Issue: 1
Author(s): T. B. Ng, Jack Ho Wong and Hexiang Wang
Affiliation:
Abstract: The intent of this article is to review recent literature on ribosome inactivating proteins (RIPs) including isolation and characterization of new RIPs, studies on the crystal structures and mechanisms of actions of RIPs, the use of saporin-based neurotoxins to selectively lesion cholinergic neurons in neuroscience research, and the use of RIP-based conjugates and immunotoxins in anticancer therapy.
Export Options
About this article
Cite this article as:
Ng B. T., Wong Ho Jack and Wang Hexiang, Recent Progress in Research on Ribosome Inactivating Proteins, Current Protein & Peptide Science 2010; 11 (1) . https://dx.doi.org/10.2174/138920310790274662
DOI https://dx.doi.org/10.2174/138920310790274662 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Kisspeptin: Paving the Way to a New Therapeutic Avenue in Reproduction
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Phosphonomethoxyalkyl Analogs of Nucleotides
Current Pharmaceutical Design Recent Developments of Flavonoids with Various Activities
Current Topics in Medicinal Chemistry Role of Imaging in Testicular Cancer
Current Medical Imaging Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation The Carnitine Transporter Network: Interactions with Drugs
Current Chemical Biology Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Recent Advances in Carbon Nanotubes as Delivery Systems for Anticancer Drugs
Current Medicinal Chemistry Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Drug Transport Across the Placenta
Current Pharmaceutical Biotechnology CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Molecular Mechanisms Underlying Psychological Stress and Cancer
Current Pharmaceutical Design Bestatin as an Experimental Tool in Mammals
Current Drug Metabolism Targeting: The ADEPT Story So Far
Current Drug Targets Alphavirus Vectors for Gene Therapy Applications
Current Gene Therapy Cell Proliferation and Cytotoxicity Assays
Current Pharmaceutical Biotechnology DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
Current Medicinal Chemistry Toxicology of Tributyltin in Mammalian Animal Models
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer
Current Medicinal Chemistry Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics